Pfizer Inc
These high-dividend-yielding stocks could see a rebound as rates decline, BMO says
Now could be a good time to start buying stocks with high dividend yields, according to BMO Capital Markets. The highest-paying S & P 500 stocks have significantly underperformed the index over the last year and a half, even with the rebound they’ve enjoyed in recent months, said chief investment strategist Brian Belski. Higher-for-longer interest […]
Read More
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris Kleponis | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round of Medicare drug price negotiations has come […]
Read More
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing lower expected sales in Europe, a “competitive environment” for respiratory vaccines in the U.S. and the potential for deferred international revenue into 2025. The biotech company now expects 2024 product revenue to come in between $3 billion to $3.5 […]
Read More
Stocks making the biggest moves premarket: CrowdStrike, Merck, PayPal, JetBlue and more
Check out the companies making headlines in premarket trading. CrowdStrike — Shares slipped 5% after CNBC reported that stated Delta Airlines has retained legal counsel to pursue damages from both CrowdStrike and Microsoft following after a software update led to mass flight interruptions in July. Woodward — The aerospace and industrial equipment company slipped more […]
Read More
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
Kena Betancur | Corbis News | Getty Images Pfizer on Thursday reported second-quarter revenue and adjusted earnings that blew past expectations and raised its full-year outlook, benefiting from its broad cost-cutting program, better-than-expected sales of its Covid antiviral pill Paxlovid and strong non-Covid product sales. The company now expects to book adjusted earnings of $2.45 to $2.65 […]
Read More
Stock futures are flat in overnight trading ahead of key corporate earnings: Live updates
Traders on the floor of the New York Stock Exchange on Aug. 4, 2022. Source: NYSE Stock futures were flat in overnight trading Monday as investors awaited key corporate earnings and the beginning of the Federal Reserve’s policy meeting. Futures on the Dow Jones Industrial Average inched up 20 points. S&P 500 futures and Nasdaq […]
Read More
These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments
The lucrative market for weight loss drugs won’t stay a duopoly forever. With billions at stake, that’s pretty much been a guarantee facing the current market leaders, Eli Lilly and Novo Nordisk , from the start. But the reality of the coming competition has grown more tangible after recent announcements from rival drugmakers Roche and […]
Read More
Pfizer’s gene therapy for rare genetic bleeding disorder succeeds in late-stage trial
Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval. The treatment for hemophilia A could become the company’s second gene therapy to enter the U.S. market after Beqvez, which […]
Read More
Op-ed: How well can AI chatbots mimic doctors in a treatment setting? We put 5 to the test
Dr. Scott Gottlieb is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. He is a CNBC contributor and is a member of the boards of Pfizer and several other startups in health and tech. He is also a partner at the venture capital firm New Enterprise Associates. Shani […]
Read More
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Novo Nordisk‘s blockbuster diabetes drug Ozempic may have more to offer beyond […]
Read More